A 17-alkylated orally active androgenic steroid. A Schedule IV drug in Canada.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Prasterone | The serum concentration of Calusterone can be increased when it is combined with Prasterone. |
| Dextrose, unspecified form | The serum concentration of Dextrose, unspecified form can be decreased when it is combined with Calusterone. |
| Propranolol | Calusterone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy. |
| Flunisolide | The risk or severity of edema formation can be increased when Calusterone is combined with Flunisolide. |
| Beclomethasone dipropionate | The risk or severity of edema formation can be increased when Calusterone is combined with Beclomethasone dipropionate. |
| Betamethasone | The risk or severity of edema formation can be increased when Calusterone is combined with Betamethasone. |
| Fluticasone propionate | The risk or severity of edema formation can be increased when Calusterone is combined with Fluticasone propionate. |
| Fluocinolone acetonide | The risk or severity of edema formation can be increased when Calusterone is combined with Fluocinolone acetonide. |
| Triamcinolone | The risk or severity of edema formation can be increased when Calusterone is combined with Triamcinolone. |
| Prednisone | The risk or severity of edema formation can be increased when Calusterone is combined with Prednisone. |
| Fludrocortisone | The risk or severity of edema formation can be increased when Calusterone is combined with Fludrocortisone. |
| Hydrocortisone | The risk or severity of edema formation can be increased when Calusterone is combined with Hydrocortisone. |
| Prednisolone | The risk or severity of edema formation can be increased when Calusterone is combined with Prednisolone. |
| Methylprednisolone | The risk or severity of edema formation can be increased when Calusterone is combined with Methylprednisolone. |
| Trilostane | The risk or severity of edema formation can be increased when Calusterone is combined with Trilostane. |
| Budesonide | The risk or severity of edema formation can be increased when Calusterone is combined with Budesonide. |
| Dexamethasone | The risk or severity of edema formation can be increased when Calusterone is combined with Dexamethasone. |
| Corticotropin | The risk or severity of edema formation can be increased when Calusterone is combined with Corticotropin. |
| Cortisone acetate | The risk or severity of edema formation can be increased when Calusterone is combined with Cortisone acetate. |
| Paramethasone | The risk or severity of edema formation can be increased when Calusterone is combined with Paramethasone. |
| Ciclesonide | The risk or severity of edema formation can be increased when Calusterone is combined with Ciclesonide. |
| Aldosterone | The risk or severity of edema formation can be increased when Calusterone is combined with Aldosterone. |
| Fluticasone furoate | The risk or severity of edema formation can be increased when Calusterone is combined with Fluticasone furoate. |
| Fluprednidene | The risk or severity of edema formation can be increased when Calusterone is combined with Fluprednidene. |
| Tixocortol | The risk or severity of edema formation can be increased when Calusterone is combined with Tixocortol. |
| Fluprednisolone | The risk or severity of edema formation can be increased when Calusterone is combined with Fluprednisolone. |
| Meprednisone | The risk or severity of edema formation can be increased when Calusterone is combined with Meprednisone. |
| Dexamethasone isonicotinate | The risk or severity of edema formation can be increased when Calusterone is combined with Dexamethasone isonicotinate. |
| Melengestrol | The risk or severity of edema formation can be increased when Calusterone is combined with Melengestrol. |
| Deflazacort | The risk or severity of edema formation can be increased when Calusterone is combined with Deflazacort. |
| Cortivazol | The risk or severity of edema formation can be increased when Calusterone is combined with Cortivazol. |
| Prednylidene | The risk or severity of edema formation can be increased when Calusterone is combined with Prednylidene. |
| Fluocortin | The risk or severity of edema formation can be increased when Calusterone is combined with Fluocortin. |
| Fluperolone | The risk or severity of edema formation can be increased when Calusterone is combined with Fluperolone. |
| Cloprednol | The risk or severity of edema formation can be increased when Calusterone is combined with Cloprednol. |
| Fluclorolone | The risk or severity of edema formation can be increased when Calusterone is combined with Fluclorolone. |
| Fluticasone | The risk or severity of edema formation can be increased when Calusterone is combined with Fluticasone. |
| Mometasone furoate | The risk or severity of edema formation can be increased when Calusterone is combined with Mometasone furoate. |
| Hydrocortisone acetate | The risk or severity of edema formation can be increased when Calusterone is combined with Hydrocortisone acetate. |
| Hydrocortisone cypionate | The risk or severity of edema formation can be increased when Calusterone is combined with Hydrocortisone cypionate. |
| Hydrocortisone succinate | The risk or severity of edema formation can be increased when Calusterone is combined with Hydrocortisone succinate. |
| Prednisolone phosphate | The risk or severity of edema formation can be increased when Calusterone is combined with Prednisolone phosphate. |
| Prednisolone hemisuccinate | The risk or severity of edema formation can be increased when Calusterone is combined with Prednisolone hemisuccinate. |
| Methylprednisolone hemisuccinate | The risk or severity of edema formation can be increased when Calusterone is combined with Methylprednisolone hemisuccinate. |
| Prednisone acetate | The risk or severity of edema formation can be increased when Calusterone is combined with Prednisone acetate. |
| Clocortolone acetate | The risk or severity of edema formation can be increased when Calusterone is combined with Clocortolone acetate. |
| Melengestrol acetate | The risk or severity of edema formation can be increased when Calusterone is combined with Melengestrol acetate. |
| Betamethasone phosphate | The risk or severity of edema formation can be increased when Calusterone is combined with Betamethasone phosphate. |
| Cortisone | The risk or severity of edema formation can be increased when Calusterone is combined with Cortisone. |
| Clobetasol propionate | The risk or severity of edema formation can be increased when Calusterone is combined with Clobetasol propionate. |
| Fluocinonide | The risk or severity of edema formation can be increased when Calusterone is combined with Fluocinonide. |
| Hydrocortisone butyrate | The risk or severity of edema formation can be increased when Calusterone is combined with Hydrocortisone butyrate. |
| Desoximetasone | The risk or severity of edema formation can be increased when Calusterone is combined with Desoximetasone. |
| Mometasone | The risk or severity of edema formation can be increased when Calusterone is combined with Mometasone. |
| Fluocortolone | The risk or severity of edema formation can be increased when Calusterone is combined with Fluocortolone. |
| Prednisolone acetate | The risk or severity of edema formation can be increased when Calusterone is combined with Prednisolone acetate. |
| Fluorometholone | The risk or severity of edema formation can be increased when Calusterone is combined with Fluorometholone. |
| Difluocortolone | The risk or severity of edema formation can be increased when Calusterone is combined with Difluocortolone. |
| Flumethasone | The risk or severity of edema formation can be increased when Calusterone is combined with Flumethasone. |
| Methylprednisolone aceponate | The risk or severity of edema formation can be increased when Calusterone is combined with Methylprednisolone aceponate. |
| Lepirudin | Calusterone may increase the anticoagulant activities of Lepirudin. |
| Bivalirudin | Calusterone may increase the anticoagulant activities of Bivalirudin. |
| Alteplase | Calusterone may increase the anticoagulant activities of Alteplase. |
| Urokinase | Calusterone may increase the anticoagulant activities of Urokinase. |
| Reteplase | Calusterone may increase the anticoagulant activities of Reteplase. |
| Anistreplase | Calusterone may increase the anticoagulant activities of Anistreplase. |
| Tenecteplase | Calusterone may increase the anticoagulant activities of Tenecteplase. |
| Abciximab | Calusterone may increase the anticoagulant activities of Abciximab. |
| Drotrecogin alfa | Calusterone may increase the anticoagulant activities of Drotrecogin alfa. |
| Streptokinase | Calusterone may increase the anticoagulant activities of Streptokinase. |
| Dicoumarol | Calusterone may increase the anticoagulant activities of Dicoumarol. |
| Argatroban | Calusterone may increase the anticoagulant activities of Argatroban. |
| Ardeparin | Calusterone may increase the anticoagulant activities of Ardeparin. |
| Phenindione | Calusterone may increase the anticoagulant activities of Phenindione. |
| Fondaparinux | Calusterone may increase the anticoagulant activities of Fondaparinux. |
| Warfarin | Calusterone may increase the anticoagulant activities of Warfarin. |
| Pentosan polysulfate | Calusterone may increase the anticoagulant activities of Pentosan polysulfate. |
| Phenprocoumon | Calusterone may increase the anticoagulant activities of Phenprocoumon. |
| Dipyridamole | Calusterone may increase the anticoagulant activities of Dipyridamole. |
| Heparin | Calusterone may increase the anticoagulant activities of Heparin. |
| Enoxaparin | Calusterone may increase the anticoagulant activities of Enoxaparin. |
| Epoprostenol | Calusterone may increase the anticoagulant activities of Epoprostenol. |
| Acenocoumarol | Calusterone may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Calusterone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Calusterone may increase the anticoagulant activities of Coumarin. |
| Ximelagatran | Calusterone may increase the anticoagulant activities of Ximelagatran. |
| Desmoteplase | Calusterone may increase the anticoagulant activities of Desmoteplase. |
| Defibrotide | Calusterone may increase the anticoagulant activities of Defibrotide. |
| Ancrod | Calusterone may increase the anticoagulant activities of Ancrod. |
| Beraprost | Calusterone may increase the anticoagulant activities of Beraprost. |
| Prasugrel | Calusterone may increase the anticoagulant activities of Prasugrel. |
| Rivaroxaban | Calusterone may increase the anticoagulant activities of Rivaroxaban. |
| Sulodexide | Calusterone may increase the anticoagulant activities of Sulodexide. |
| Semuloparin | Calusterone may increase the anticoagulant activities of Semuloparin. |
| Idraparinux | Calusterone may increase the anticoagulant activities of Idraparinux. |
| Cangrelor | Calusterone may increase the anticoagulant activities of Cangrelor. |
| Astaxanthin | Calusterone may increase the anticoagulant activities of Astaxanthin. |
| Apixaban | Calusterone may increase the anticoagulant activities of Apixaban. |
| Otamixaban | Calusterone may increase the anticoagulant activities of Otamixaban. |
| Amediplase | Calusterone may increase the anticoagulant activities of Amediplase. |